
    
      Therefore, the investigators of this study are investigating whether SHR1459 could prevent
      relapse of NMOSDs.

      The primary objective of this study is to evaluate the effectiveness of SHR1459 in NMOSDs
      patients.

      The secondary objectives are to determine:

      The safety profile of SHR 1459 in patients with NMOSDs. Whether SHR1459 reduce MRI lesions
      and APQ4-Abs level.
    
  